The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein

Neuropathology and Applied Neurobiology

Volumn 30, Issue 1, 2004, Pages 1-18

  Taniguchi, S ^a,b   McDonagh, A M ^c   Pickering Brown, S M ^d   Umeda, Y ^a   Iwatsubo, T ^b   Hasegawa, M ^a   Mann, D M A ^c,e  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e HOPE HOSPITAL   (United Kingdom)

Author keywords

Frontotemporal dementia; Immunohistochemistry; RT PCR; Tau; Western blotting

Indexed keywords

ALPHA SYNUCLEIN; CELL MARKER; PROTEIN NEUN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; APHASIA; ARTICLE; BRAIN CORTEX; CELL INCLUSION; CHROMOSOME 17; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; GENE MUTATION; GLIA CELL; GLIOSIS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE; MOTOR NEURON DISEASE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPATHOLOGY; PARKINSONISM; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL LOBE; WESTERN BLOTTING; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN; DEMENTIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; MUTATION; NEUROGLIA; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAU PROTEINS;

EID: 0842265475     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2003.00481.x     Document Type: Article

References (46)

1. Snowden JS, Neary D, Mann DMA. Frontotemporal Lobar Degeneration: Frontotemporal Dementia, Progressive Aphasia. Semantic Dementia. New York: Churchill Livingstone, 1996
2. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr 1987; 6: 193-207
3. Mann DMA, South PW, Snowden JS, Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatr 1993; 56: 605-14
4. Brun A, Englund E, Gustafson L, Passant U, Mann DMA, Neary D, Snowden JS. Clinical, neuropsychological and neuropathological criteria for fronto-temporal dementia. J Neurol Neurosurg Psychiatr 1994: 57; 416-8
5. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF, Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54
6. Jackson M, Lennox G, Löwe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996; 5: 339-50
7. Neary D, Snowden JS, Mann DMA, Northern B, Goulding PJ, MacDermott N. Frontal lobe dementia and motor neurone disease. J Neurol Neurosurg Psychiatr 1990; 53: 23-32
8. Mann DMA, Neary D, Snowden JS. Chromosome 17 and Frontotemporal dementia. In Alzheimer's Disease and Related Disorders Annual. Eds S Gauthier, J Cummings. London: Martin Durnitz Ltd. 2000: 27-55
9. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Ageing 2001; 22: 89-107
10. Tolnay M, Probst A. Frontotemporal lobar degeneration -tau as a pied piper? Neurogenetics 2002; 4: 63-75
11. Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Neary D, Crauford D, Snowden JS, Mann D, Hutton M. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999; 46: 243-8
12. Pickering-Brown SM, Richardson AMT, Snowden JS, McDonagh AM, Burns A, Braude W, Baker M, Liu W-K, Yen S-H, Hardy J, Hutton M, Davies Y, Allsop D, Craufurd D, Neary D, Mann DMA. Inherited frontotemporal dementia in 9 British families associated with intronic mutations in the tau gene. Brain 2002; 125: 732-51
13. Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992; 8: 159-68
14. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VMD, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VM-Y. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001; 49: 165-75
15. Wong H, Anderson WD, Cheng T, Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: the primer-dropping method. Anal Biochem 1994; 223: 251-8
16. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden M, Pickering-Brown SM, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaf E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski JQ, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd P, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann DM, Lynch T, Heutink P. Association of missense and 5′-splice-site mutation in tau with inherited dementia FTDP-17. Nature 1998; 393: 702-5
17. Spillantini MG, Crowther RA, Kamphorst W, Heutink P, Van Swieten JC. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. Am J Pathol 1998; 153: 1359-63
18. Kato S, Nakamura H. Presence of two different fibril subtypes in Pick bodies: an immunoelectron microscopic study. Acta Neuropathol 1990; 81: 125-9
19. Love S, Burrola P, Terry RD, Wilet CA. Immunoelectron microscopy of Alzheimer and Pick brain tissue labelled with the monoclonal antibody Alz 50. Neuropathol Appl Neurobiol 1989; 15: 223-31
20. Muruyama S, Mori H, Ihara Y, Tomonaga M. Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neurol 1990; 27: 394-405
21. Zhukareva V, Mann D, Pickering-Brown SM, Uryu K, Shuck T, Shah K, Grossman M, Miller BL, Hulette CM, Feinstein S, Trojanowski JQ, Lee VM-Y. Sporadic Pick's disease: a tauopathy characterised by a spectrum of pathological tau isoforms in gray and white matter. Ann Neurol 2002; 51: 730-9
22. Lippa CF, Zhukareva V, Kawarai T, Uryu K, Shafiq M, Nee LE, Trojanowski JQ, Lee VM-Y. Frontotemporal dementia with novel tau pathology and a Glu342 Val mutation. Ann Neurol 2000; 48: 850-8
23. Murrell JR, Spillantini MG, Zolo P, Guazelli M, Smith MJ, Hasegawa M, Redi F, Crowther RA, Piertrini P, Ghetti B, Goedert M. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol 1999; 58: 1207-26
24. Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA. Pick's disease associated with the novel tau gene mutation K369I. Ann Neurol 2001; 50: 503-13
25. Pickering-Brown SM, Baker M, Yen S-H, Liu W-K, Hasegawa M, Cairns NJ, Lantos PL, Rossor M, Iwatsubo T, Davies Y, Allsop D, Furlong R, Owen F, Hardy J, Mann DMA, Hutton M. Pick's disease is associated with mutations in the tau gene. Ann Neurol 2000; 48: 859-67
26. Rizzini C, Goedert M, Hodges J, Smith MJ, Jakes R, Hills R, Xuereb RH, Crowther RA, Spillantini MG. Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol 2000; 59: 990-1001
27. Delacourte A, Robitaille Y, Sergeant N, Buee L, Hof PR, Wattez A, Laroche-Cholette A, Matthieu J, Chagnon P, Gavreau D. Specific pathological tau protein variants characterise Pick's disease. J Neuropathol Exp Neurol 1996; 55: 159-68
28. Delacourte A, Sergeant N, Wattez J, Gavreau D, Robitaille Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol 1998; 43: 193-204
29. Lieberman AP, Trojanowski JQ, Lee VM-Y, Balin BJ, Ding XS, Greenberg J, Morrison D, Reivich M, Grossman M. Cognitive, neuroimaging and pathological studies in a patient with Pick's disease. Ann Neurol 1998; 43: 259-65
30. Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG. Pick's disease: hyperphosphorylated tau protein segregates to the somato-axonal compartment. Acta Neuropathol 1996; 92: 588-96
31. 262 antibody recognises a variety of abnormal hyperphosphorylated tau deposits inn tauopathies including Pick bodies and argyrophilic grains. Acta Neuropathol 2002; 104: 658-64
32. Buee L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration. FTDP-17 and Pick's disease. Brain Pathol 1999; 9: 681-93
33. Aral T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Scwab C, McGeer PL. Distinct isoforms of tau aggregated in neurones and glial cells in brains of patients with Pick's disease, corticobasal degeneration and supranuclear palsy. Acta Neuropathol 2001; 101: 167-73
34. King M, Ghoshal N, Wall NS, Binder LI, Ksiezak-Reding H. Structural analysis of Pick's-disease-derived and in-vitro assembled tau filaments. Am J Pathol 2001; 158: 1481-90
35. Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, Yen S-H, Dickson DW. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer disease, progressive supranuclear palsy and Pick's disease. Acta Neuropathol 2000; 100: 235-44
36. Gydesen S, Hagen S, Klinken L. Neuropsychiatric studies in a family with presenile dementia different from Alzheimer and Pick disease. Acta Psychiatr Scand 1987; 76: 276-84
37. Brown J, Ashworth A, Gydesen S et al. Familial non-specific dementia maps to chromosome 3. Hum Molec Genet 1995; 4: 1625-8
38. Hosler B, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH Jr. Linkage of familial Amyotrophic Lateral Sclerosis with Frontotemporal Dementia to chromosome 9q21-22. JAMA 2000; 284: 1664-9
39. Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel J-P, Growdon JH, Trojanowski JQ, Lee VM-Y, Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol 200 (in press)
40. Adamec E, Chang HT, Stopa EG, Hedreen JC, Vonsattel JP, Tau protein expression in frontotemporal dementias. Neurosci Lett 2001; 315: 21-4
41. Mann DMA, South PW. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol 1993; 85: 335-4
42. Gibb WRG, Mountjoy CQ, Mann DMA, Lees AJ. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome. J Neurol Neurosurg Psychiatr 1989; 52: 193-200
43. Lippa C, Fujiwara H, Mann DMA, Glassion B, Baba M, Schmidt ML, Nee L, O'Connell B, Pollen D, St George Hyslop PH, Ghetti B, Nochlin D, Lee VM-Y, Iwatsubo T, Trojanowski JQ. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998; 153: 1365-70
44. Lippa CF, Schmidt ML, Lee VM-Y, Trojanowski JQ. Antibodies to alpha-synuclein detect Lewy bodies in many brains with Alzheimer's disease. Ann Neurol 1999; 45: 353-7
45. Pickering-Brown SM, Owen F, Isaacs A, Snowden JS, Varma A, Neary D, Furlong R, Daniel SE, Cairns NJ. Mann DMA. Apolipoprotein E ε4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with Pick-or microvacuolar-type histology. Exp Neurol 2000; 163: 452-6
46. Mann DMA, McDonagh AM, Pickering-Brown SM, Kowa H, Iwatsubo T. Amyloid β protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype. Neurosci Lett 2001; 304: 161-4